Immune checkpoint assays are essential for evaluating immune modulation in cancer therapy. These assays help assess binding interactions, functional activity, and potency of immune checkpoint inhibitors. Techniques such as T cell proliferation assays, cytokine release assays, and cytotoxicity tests provide insights into immune response regulation. By optimizing assay conditions, researchers can develop effective immunotherapies, ensuring precise immune checkpoint targeting for enhanced therapeutic outcomes.